Cargando…
Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide
Glioblastoma multiforme (GBM) is the most aggressive type of human primary brain tumor. The standard treatment protocol includes radiotherapy in combination with temozolomide (TMZ). Despite advances in GBM treatment, the survival time of patients diagnosed with glioma is 14.5 months. Regarding tumor...
Autores principales: | Sales, Thais Torquato, Resende, Fernando Francisco Borges, Chaves, Natália Lemos, Titze-De-Almeida, Simoneide Souza, Báo, Sônia Nair, Brettas, Marcella Lemos, Titze-De-Almeida, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038559/ https://www.ncbi.nlm.nih.gov/pubmed/27698831 http://dx.doi.org/10.3892/ol.2016.4992 |
Ejemplares similares
-
The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells
por: Horst, Camila Hillesheim, et al.
Publicado: (2017) -
Progress in circRNA-Targeted Therapy in Experimental Parkinson’s Disease
por: Titze-de-Almeida, Simoneide Souza, et al.
Publicado: (2023) -
Delivery of miRNA-Targeted Oligonucleotides in the Rat Striatum by Magnetofection with Neuromag(®)
por: Titze de Almeida, Simoneide Souza, et al.
Publicado: (2018) -
Overexpression of Eag1 potassium channels in clinical tumours
por: Hemmerlein, Bernhard, et al.
Publicado: (2006) -
The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease
por: Titze-de-Almeida, Simoneide S., et al.
Publicado: (2020)